Trials / Unknown
UnknownNCT03931265
Ketohexokinase Isoforms in Endometrial Cancer.
Prognostic Evaluations of Ketohexokinase Isoforms in Endometrial Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 220 (estimated)
- Sponsor
- Far Eastern Memorial Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Our preliminary analysis with clinical database suggested that, in patients with type I endometrial cancer, high ketohexokinase-expressing group have lower survival probabilities than low ketohexokinase-expressing group. To understand the importance of ketohexokinase expression and isoform switch during the development of type I endometrial cancer, we propose a series of in vitro experiments and clinical examinations in this project.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | ketohexokinase | Check the isoforms of ketohexokinase in the specimen of endometrial cancer |
Timeline
- Start date
- 2019-04-11
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2019-04-30
- Last updated
- 2023-09-15
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03931265. Inclusion in this directory is not an endorsement.